Commentary: One-year quality of life among post-hospitalization COVID-19 patients.
作者信息
Finsterer Josef
机构信息
Neurology & Neurophysiology Center, Vienna, Austria.
出版信息
Front Public Health. 2024 Jul 3;12:1417068. doi: 10.3389/fpubh.2024.1417068. eCollection 2024.
Abstract
摘要
相似文献
1
Commentary: One-year quality of life among post-hospitalization COVID-19 patients.评论：新冠病毒感染康复出院患者的一年生活质量
Front Public Health. 2024 Jul 3;12:1417068. doi: 10.3389/fpubh.2024.1417068. eCollection 2024.
2
SARS-CoV-2 Infection and Hospitalization Among Adults Aged ≥18 Years, by Vaccination Status, Before and During SARS-CoV-2 B.1.1.529 (Omicron) Variant Predominance - Los Angeles County, California, November 7, 2021-January 8, 2022.SARS-CoV-2 感染和≥18 岁成年人住院情况，按疫苗接种状态，在 SARS-CoV-2 B.1.1.529（奥密克戎）变异株流行之前和期间——加利福尼亚州洛杉矶县，2021 年 11 月 7 日-2022 年 1 月 8 日。
MMWR Morb Mortal Wkly Rep. 2022 Feb 4;71(5):177-181. doi: 10.15585/mmwr.mm7105e1.
3
SARS-CoV-2 Infections and Hospitalizations Among Persons Aged ≥16 Years, by Vaccination Status - Los Angeles County, California, May 1-July 25, 2021.2021 年 5 月 1 日至 7 月 25 日，加利福尼亚州洛杉矶县≥16 岁人群中，根据疫苗接种状况划分的 SARS-CoV-2 感染和住院情况。
MMWR Morb Mortal Wkly Rep. 2021 Aug 27;70(34):1170-1176. doi: 10.15585/mmwr.mm7034e5.
4
Influence of oral condition on the quality of life of patients hospitalized for COVID-19.口腔状况对因COVID-19住院患者生活质量的影响。
Oral Dis. 2024 Oct;30(7):4802-4803. doi: 10.1111/odi.14881. Epub 2024 Feb 20.
5
A longitudinal SARS-CoV-2 biorepository for COVID-19 survivors with and without post-acute sequelae.SARS-CoV-2 生物库的纵向研究，用于 COVID-19 幸存者，包括有无急性后期后遗症。
BMC Infect Dis. 2021 Jul 13;21(1):677. doi: 10.1186/s12879-021-06359-2.
6
Clinical Characteristics and Outcomes Among Adults Hospitalized with Laboratory-Confirmed SARS-CoV-2 Infection During Periods of B.1.617.2 (Delta) and B.1.1.529 (Omicron) Variant Predominance - One Hospital, California, July 15-September 23, 2021, and December 21, 2021-January 27, 2022.2021 年 7 月 15 日至 9 月 23 日和 2021 年 12 月 21 日至 2022 年 1 月 27 日期间，加利福尼亚州一家医院因实验室确诊的 SARS-CoV-2 感染住院的成年人的临床特征和结局，期间 B.1.617.2（德尔塔）和 B.1.1.529（奥密克戎）变异株占主导地位。
MMWR Morb Mortal Wkly Rep. 2022 Feb 11;71(6):217-223. doi: 10.15585/mmwr.mm7106e2.
7
Laboratory-Confirmed COVID-19 Among Adults Hospitalized with COVID-19-Like Illness with Infection-Induced or mRNA Vaccine-Induced SARS-CoV-2 Immunity - Nine States, January-September 2021.2021 年 1 月至 9 月，九个州感染诱导或 mRNA 疫苗诱导的 SARS-CoV-2 免疫的具有 COVID-19 样疾病住院成人的实验室确诊 COVID-19。
MMWR Morb Mortal Wkly Rep. 2021 Nov 5;70(44):1539-1544. doi: 10.15585/mmwr.mm7044e1.
8
Analysis of Rituximab Use, Time Between Rituximab and SARS-CoV-2 Vaccination, and COVID-19 Hospitalization or Death in Patients With Multiple Sclerosis.分析利妥昔单抗的使用、利妥昔单抗与 SARS-CoV-2 疫苗接种之间的时间间隔以及多发性硬化症患者 COVID-19 住院或死亡的情况。
JAMA Netw Open. 2022 Dec 1;5(12):e2248664. doi: 10.1001/jamanetworkopen.2022.48664.
9
Incidence of post-COVID psychiatric disorders according to the periods of SARS-CoV-2 variant dominance: The LIFE study.根据 SARS-CoV-2 变异主导时期，COVID 后精神障碍的发生率：LIFE 研究。
J Psychiatr Res. 2024 Jun;174:12-18. doi: 10.1016/j.jpsychires.2024.04.010. Epub 2024 Apr 4.
10
COVID-19 Cases and Hospitalizations by COVID-19 Vaccination Status and Previous COVID-19 Diagnosis - California and New York, May-November 2021.COVID-19 病例和住院情况按 COVID-19 疫苗接种状况和既往 COVID-19 诊断情况划分-加利福尼亚州和纽约州，2021 年 5 月至 11 月。
MMWR Morb Mortal Wkly Rep. 2022 Jan 28;71(4):125-131. doi: 10.15585/mmwr.mm7104e1.
引用本文的文献
1
Editorial: On the cusp of the silent wave of the long COVID pandemic: why, what and how should we tackle this emerging syndrome in the clinic and population?社论：处于长期新冠疫情无声浪潮的风口浪尖：在临床和人群中，我们为何、如何应对以及应如何应对这一新兴综合征？
Front Public Health. 2024 Oct 23;12:1483693. doi: 10.3389/fpubh.2024.1483693. eCollection 2024.
本文引用的文献
1
One-year quality of life among post-hospitalization COVID-19 patients.COVID-19 患者出院后一年的生活质量。
Front Public Health. 2023 Oct 6;11:1236527. doi: 10.3389/fpubh.2023.1236527. eCollection 2023.
Zotero 插件